Even though MAO-B inhibition is recognized as a mechanism contributing to treating PD and AD, selective MAO-A inhibitors could be used to treat depressive forms often associated with the early phases of cognitive decline related to AD [50]. Here, MAOB is linked to Parkinson disease.